Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Liddell

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Antioxidants (Basel, Switzerland)|August 19, 2017
Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Jeffrey R Liddell
Neurodegenerative Disease Management|August 22, 2015
Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegenerationJeffrey R Liddell
Neurochemistry International|June 5, 2017
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's diseaseJeffrey R Liddell, Anthony R White
Cell Death and Differentiation|June 8, 2021
Molecular mechanisms of cell death in neurological diseasesDiane Moujalled, Andreas Strasser, Jeffrey R Liddell
The International Journal of Biochemistry & Cell Biology|September 4, 2016
Circumventing the Crabtree Effect: A method to induce lactate consumption and increase oxidative phosphorylation in cell cultureAlexandra I Mot, Jeffrey R Liddell, Anthony R White, et al.
Frontiers in Neuroscience|July 26, 2018
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in NeurodegenerationMoataz Abdalkader, Riikka Lampinen, Katja M Kanninen, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's diseaseThomas J Telfer, Jeffrey R Liddell, Clare Duncan, et al.
Life (Basel, Switzerland)|November 7, 2020
Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and BeyondSara Nikseresht, James B W Hilton, Kai Kysenius, et al.
Analytical and Bioanalytical Chemistry|September 16, 2018
A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samplesKai Kysenius, Bence Paul, James B Hilton, et al.
Journal of Neurochemistry|October 6, 2023
Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseasesJessica L Billings, James B W Hilton, Jeffrey R Liddell, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Antioxidants (Basel, Switzerland)|August 19, 2017
Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Jeffrey R Liddell
Neurodegenerative Disease Management|August 22, 2015
Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegenerationJeffrey R Liddell
Neurochemistry International|June 5, 2017
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's diseaseJeffrey R Liddell, Anthony R White
Cell Death and Differentiation|June 8, 2021
Molecular mechanisms of cell death in neurological diseasesDiane Moujalled, Andreas Strasser, Jeffrey R Liddell
The International Journal of Biochemistry & Cell Biology|September 4, 2016
Circumventing the Crabtree Effect: A method to induce lactate consumption and increase oxidative phosphorylation in cell cultureAlexandra I Mot, Jeffrey R Liddell, Anthony R White, et al.
Frontiers in Neuroscience|July 26, 2018
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in NeurodegenerationMoataz Abdalkader, Riikka Lampinen, Katja M Kanninen, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's diseaseThomas J Telfer, Jeffrey R Liddell, Clare Duncan, et al.
Life (Basel, Switzerland)|November 7, 2020
Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and BeyondSara Nikseresht, James B W Hilton, Kai Kysenius, et al.
Analytical and Bioanalytical Chemistry|September 16, 2018
A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samplesKai Kysenius, Bence Paul, James B Hilton, et al.
Journal of Neurochemistry|October 6, 2023
Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseasesJessica L Billings, James B W Hilton, Jeffrey R Liddell, et al.
Pageof 4